In the first patient who received the Russian vaccine, metastases disappeared. During four months of follow-up, the doctors did not detect any new tumors, said the head of the Gamaliya Scientific Center, Alexander Gintsburg.
Knock on wood: It looks like it's been four months and he's doing great. As of yesterday, no neoplasm was detected.
- said Gunzburg.
The Russian cancer vaccine is based on mRNA technology. Its principle is to train the immune system to recognize the individual characteristics of a malignant tumor and direct the body's defense cells to fight it. Six people have already received the vaccine, and by the end of 2026, experts expect to start treating 20 patients.